Anna Forsythe BA, BS, MSc, MBA, PharmD

Dr. Anna Forsythe is Senior Director and Head of Global Value and Access Strategy at Eisai Inc. Anna’s team has a responsibility for understanding payer perspectives and developing the market access strategy for the entire Eisai portfolio, including the payer value proposition, pricing strategy, outcomes research, health economics and reimbursement support across all disease areas and all markets.

Anna has more than 18 years of experience in global product commercialization and strategic drug development, market access, HEOR, pricing and reimbursement across major pharmaceutical companies covering multiple therapeutic areas. Anna is a frequent and contributor to forums, articles, conferences and a guest lecturer at Rutgers University Business School addressing issues related to value of therapies, health economics evaluations and access to medicines. Previously to Eisai, Anna was a Director of Worldwide Health Outcomes, Value and Access for Novartis Oncology and prior to that, she held positions of increasing responsibility at Novartis, Schering AG and Savient pharmaceuticals. Anna has a doctorate degree in Pharmacy, a Master of Science in Health Economics and Public Policy and a Master in Business Administration.